Exploring a mother-child patient population for which mothers received a flu vaccine during pregnancy to understand virus protection for the child after birth using Truveta Studio
Truveta delivers largest and most complete mother and child EHR dataset to advance healthcare
25 avr. 2024 09h00 HE | Truveta
BELLEVUE, Wash., April 25, 2024 (GLOBE NEWSWIRE) -- Truveta, the company with a mission of Saving Lives with Data, announced today the largest and most complete mother-child electronic health record...
Truveta is a growing collective of health systems that provide more than 18% of all daily clinical care in the US.
CDC awards Truveta a real-world data contract to study COVID, maternal health, and pediatric care
22 janv. 2024 09h00 HE | Truveta
BELLEVUE, Wash., Jan. 22, 2024 (GLOBE NEWSWIRE) -- Today, Truveta, a growing collective of 30 health systems with a shared mission of Saving Lives with Data, was awarded a contract with the U.S....
Truveta Research found that patients with overweight or obesity taking tirzepatide (Mounjaro) experienced a greater percentage change in body weight than those taking semaglutide (Ozempic) for weight loss.
Largest real-world study finds tirzepatide (Mounjaro) up to three times more effective than semaglutide (Ozempic) for weight loss
27 nov. 2023 09h00 HE | Truveta
BELLEVUE, Wash., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Today Truveta announced new comparative effectiveness research exploring weight loss among patients taking semaglutide (Ozempic) and tirzepatide...
One of 2.7 million redacted echocardiogram reports available for study in Truveta.
Truveta announces availability of millions of echocardiogram reports to advance cardiovascular research
08 nov. 2023 09h00 HE | Truveta
BELLEVUE, Wash., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Today Truveta announced the availability of more than 56.6 million clinical observations from more than 2.7 million echocardiogram reports from...
Truveta is a growing collective of health systems that provide more than 18% of all daily clinical care in the US.
More than 50 organizations choose Truveta for the most complete, timely, and clean EHR data to study safety and effectiveness, improve patient care, and train medical AI
23 oct. 2023 09h00 HE | Truveta
Bellevue, WASH., Oct. 23, 2023 (GLOBE NEWSWIRE) -- Truveta announced today that it is partnering with more than 50 organizations in life sciences, healthcare, government, academic medical centers,...
Medical Components, Inc. and Truveta partnership
Medical Components Inc. and Truveta partner to advance care for patients living with cancer and chronic kidney disease
12 sept. 2023 09h00 HE | Truveta
BELLEVUE, Wash., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Medical Components, Inc. is partnering with Truveta to advance the use of real-world data to improve clinical care for patients battling cancer...
SYA dark blue font on white background (1).jpg
Custom Research Presented at AMIA Informatics Summit Reveals Promising Findings for Healthcare Innovation
14 mars 2023 08h05 HE | Syapse
SAN FRANCISCO, March 14, 2023 (GLOBE NEWSWIRE) -- Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care,...
Xtalks Webinar - Verana Health & Axtria
Axtria® To Talk About How Electronic Health Record Real-world Data Can Augment Clinical Insights on Xtalks Webinar
20 juin 2022 08h00 HE | Axtria Inc.
Berkeley Heights, NJ, June 20, 2022 (GLOBE NEWSWIRE) -- With real-world evidence (RWE) increasingly being discussed as an important indicator for determining the value of new patient therapies and...
SYA dark blue font on white background (1).png
Bayhealth Collaborates with Syapse, Bringing Data-Driven Approach to Oncology Care
15 déc. 2021 10h00 HE | Syapse
SAN FRANCISCO and DOVER, Del., Dec. 15, 2021 (GLOBE NEWSWIRE) -- Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing...
SYA dark blue font on white background (1).png
Syapse Announces New Studies Published at Virtual ISPOR Europe 2021
06 déc. 2021 11h00 HE | Syapse
SAN FRANCISCO, Dec. 06, 2021 (GLOBE NEWSWIRE) -- Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care,...
Page suivante keyboard_arrow_right